Page last updated: 2024-08-16

thalidomide and icotinib

thalidomide has been researched along with icotinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bao, Y; Chen, Q; Liu, L; Sun, X; Wang, Y; Xu, Y	1

Other Studies

1 other study(ies) available for thalidomide and icotinib

Article	Year
Synergistic Inhibition of Thalidomide and Icotinib on Human Non-Small Cell Lung Carcinomas Through ERK and AKT Signaling. Medical science monitor : international medical journal of experimental and clinical research, 2018, May-15, Volume: 24 Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Crown Ethers; Drug Synergism; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Thalidomide; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2	2018

Article

Year

Synergistic Inhibition of Thalidomide and Icotinib on Human Non-Small Cell Lung Carcinomas Through ERK and AKT Signaling.

Medical science monitor : international medical journal of experimental and clinical research, 2018, May-15, Volume: 24

Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Crown Ethers; Drug Synergism; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Thalidomide; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2018